Federal prime contract award
Recipient: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Awarding agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
Description: CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL
Award type: DEFINITIVE CONTRACT
Award amount: $213770068
Total outlays: $174002947.06
Period of performance: 2022-08-29 to 2028-10-01
NAICS: 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC: AJ15 — GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; R&D FACILITIES & MAJ EQUIP
Place of performance (state): NC